STOCK ALARM
PRO
SA
PRO
Market
Screener
Charts
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
Anavex Life Sciences Corp.
AVXL
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
As of
2025
• vs 2024
Annual
Quarterly
Per Share
Revenue/Share
$0.00
Net Income/Share
$0.00
Operating CF/Share
$-0.46
-24.0%
Free CF/Share
$-0.46
-24.0%
Cash/Share
$1.20
-24.1%
Book Value/Share
$1.11
-22.8%
Tangible Book/Share
$1.11
-22.8%
Equity/Share
$1.11
-22.8%
Interest Debt/Share
$0.00
Valuation
Market Cap
$759.08M
+60.1%
Enterprise Value
$656.50M
+92.0%
P/E Ratio
0.00
P/S Ratio
0.00
P/OCF Ratio
-19.44
-26.4%
P/FCF Ratio
-19.44
-26.4%
P/B Ratio
8.00
+103.0%
P/TB Ratio
8.00
+103.0%
EV/Sales
0.00
EV/EBITDA
0.00
Profitability
Earnings Yield
0.00%
FCF Yield
-5.14%
+20.9%
ROE
0.00%
ROIC
0.00%
Return on Tangible Assets
0.00%
Capital Allocation
CapEx/OCF
0.00%
CapEx/Revenue
0.00%
CapEx/Depreciation
0.00
SBC/Revenue
0.00%
Balance Sheet
Debt/Equity
0.00
Debt/Assets
0.00
Net Debt/EBITDA
0.00
Current Ratio
11.60
+31.0%
Interest Coverage
0.00x
Income Quality
0.84
+17.5%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
$0.00
Graham Net-Net
$1.10
-22.3%